Penn Medicine Abramson Cancer Center


 

Penn Medicine Abramson Cancer Center Updates on Managing CLL/SLL With Practical Considerations for Novel Agents

319 views
January 19, 2024

Chapters

Overview of CLL/SLL, Signs & Symptoms

00:00

Risk Factors & Diagnosing CLL/SLL

02:33

Genetic Testing & Prognostic Factors in CLL

03:44

Rai & Binet Staging Systems for CLL

09:11

Complications from CLL & Approach to Treatment

10:11

BTK Inhibitors for CLL: Ibrutinib, Acalabrutinib & Zanubrutinib

15:59

Venetoclax-Based Therapy & Side Effects

21:47

Anti-CD20 Monoclonal Antibody Therapy for CLL

25:23

Emerging Treatments & Complications Management for CLL

26:55

Comments 0
Login to view comments. Click here to Login